Bradley A. Jacobson

• Represented hedge funds, venture capital funds, private equity funds and investment advisers in connection with numerous investments in software, biotechnology, internet, media and entertainment, fintech and other technology companies.
• Represented public companies in connection with their investment in strategic partners.
• Represented private companies in connection with fundraising activities.

Representative matters:

• Represented institutional investor in $530 million Series B financing of Aurora Innovation, Inc., a leading developer of self-driving technology.
• Represented institutional investor in $300 million Series C financing of Bird Rides, Inc., a leading electric scooter sharing company.
• Represented institutional investor in $165 million Series D financing of ServiceTitan, Inc., the leading software provider for home services businesses.
• Represented institutional investor in $400 million Series F financing of Compass, a technology-driven real estate platform.
• Represented institutional investor in $50 million Series C financing of Allbirds, Inc., a maker of eco-friendly merino wool shoes in casual styles.
• Represented institutional investor in $185 million Series C financing of Convoy, Inc., a digital freight broker.
• Represented institutional investor in $427 million Series H financing of Slack Technologies, a leading cloud-based workplace collaboration platform.
• Represented institutional investor in $125 million Series C financing of Atreca, Inc., a biotechnology company focused on developing novel therapeutics drawn from human immune responses.
• Represented institutional investor in $90 million Series D financing of PagerDuty, a global leader in digital operations management.
• Represented institutional investor in $120 million convertible note financing of Allogene Therapeutics, a clinical-stage biotechnology company pioneering the development of allogeneic CAR T therapies for cancer.
• Represented institutional investor in $110 million Series E financing of Tempus Labs, Inc., a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data.
• Represented institutional investor in $550 million Series F financing of Peloton Interactive, Inc., the global fitness technology company.
• Represented institutional investor in $140 million Series C financing of Gusto, the leading payroll, benefits and HR technology platform for small businesses.
• Represented institutional investor in $600 million Series I financing of Lyft, Inc., a leading rideshare company.
• Represented institutional investor in $335 million Series C financing of Lime, a leading scooter and bike sharing company.
• Represented institutional investor in $125 million Series G financing of Rover, the world’s largest network of pet sitters and dog walkers.
• Represented institutional investor in $150 million Series G financing of Fuze, Inc., a leading cloud-based communications solution provider for the modern global enterprise.
• Represented institutional investor in $80 million Series B financing of Fulcrum Therapeutics, Inc., a company focused on discovering and developing small molecule therapies to unlock gene control and treat serious genetic diseases.
• Represented institutional investor in $100 million Series C financing of Checkr, Inc., a leading background checks platform for the modern economy.
• Represented institutional investor in $50 million Series C financing of Goop, the modern lifestyle brand founded by Gwyneth Paltrow.
• Represented institutional investor in $150 million Series C financing of Reddit, Inc., a social news aggregation, web content rating, and discussion website.
• Represented institutional investor in $500 million Series F financing of Deliveroo, a British online food delivery company.
• Represented institutional investor in $250 million Series F financing of 23andMe, Inc., a leading personal genetics company.
• Represented institutional investor in $132 million Series D financing of Outset Medical, Inc., a pioneering medical technology company that develops a hemodialysis system for kidney diseases.
• Represented institutional investor in $500 million Series G financing of Moderna Therapeutics, a life sciences company pioneering the development of a new class of drugs made of messenger RNA (mRNA).
• Represented institutional investor in $50 million Series C financing of Principia Biopharma Inc., a biopharmaceutical company dedicated to bringing transformative oral therapies to patients with significant unmet medical needs in immunology and oncology.
• Represented institutional investor in $65 million Series C financing of AgBiome, which discovers and develops innovative biological and trait products for crop protection.
• Represented institutional investor in $30 million Series C financing of Framebridge, Inc., an on-line custom framing company.
• Represented institutional investor in $20 million Series A financing of JetClosing, a leader in digital real estate title and settlement transactions.
• Represented institutional investor in $45 million Series B financing of Nohla Therapeutics, a leading developer of universal, off-the-shelf cell therapies for patients with hematologic malignances and other critical diseases.
• Represented institutional investor in $100 million Series F financing of Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing tumor-targeted and immuno-oncology therapies based on its pioneering research and development in cancer epigenetics.
• Represented institutional investor in $100 million Series C financing of Reflexion Medical, Inc., a medical technology company developing the first and only biology-guided radiotherapy system (BgRT) for targeted cancer treatment.
• Represented institutional investor in $100 million Series D financing of Tempus Labs, Inc., a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data.
• Represented institutional investor in $80 million Series C financing of Evelo Biosciences, Inc., a biotechnology company pioneering the therapeutic modality of monoclonal microbials.
• Represented institutional investor in $100 million Series C financing of Rubius Therapeutics, Inc., a company developing Red-Cell Therapeutics as a new treatment modality to address a wide array of indications including cancer, autoimmune disease, rare disease and metabolic disease.

• Represented issuers and underwriters in connection with more than 20 public offerings of equity and debt securities totaling more than $1.5 billion.
• Represented public companies, investors and placement agents in numerous PIPE transactions.

• Represented a public medical device company in connection with a $1.3 billion merger/spin-off transaction.
• Represented the nation's largest specialty retailer of big and tall men's apparel in the acquisition of a major competitor.
• Represented a public biotech company in the acquisition of a private vaccine company in a merger.
• Represented one of the nation's largest banks in connection with the acquisition of the commercial banking business of a competitor.
• Represented a major office REIT in connection with its $1.2 billion acquisition of the Embarcadero Center in San Francisco.
• Represented nationally recognized REITs in numerous property acquisitions using equity securities.
• Represented investors in exit transactions via mergers and acquisitions.

• Selected, Massachusetts Lawyers Weekly, “Go To Business Transactions Lawyer,” 2022
• Listed, Chambers USA Guide, Private Equity: Venture Capital Investment, 2023
• Listed, The Legal 500 United States, M&A/Corporate and Commercial - Venture Capital and Emerging Companies, 2021-2022
  • "Recommended Lawyer," 2022
  • "Other Key Lawyer," 2022
• Listed, Boston magazine, "Top Lawyers - Corporate Law," 2022-2023
• Listed, Acritas Stars™ Independently Rated Lawyers, “Star Lawyers,” 2019-2021
• Team Member, Corporate Board Member magazine and FTI Consulting Inc., one of "America’s Best Corporate Law Firms," 13^th Annual Legal Industry Study, 2013
• Listed, Super Lawyers magazine, Super Lawyers of Massachusetts, "Rising Star," 2005-2006

• Member, Boston Bar Association
• Member, Massachusetts Bar Association